Shares of Arcturus Therapeutics crashed more than 60% early Wednesday on mixed test results for its experimental cystic ...
Immunai collected a hefty $215 million series B round back in 2021 after raising $60 million through a series A earlier that same year. Those funds have helped the company stretch its reach from ...
Data center infrastructure firm Vertiv beat expectations for the third quarter and guided above views for the current period.
Spyre Therapeutics, Inc. ('Spyre” or the 'Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...
Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025, and subsequently was awarded the FDA Commissioner’s National ...
The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains.
Take-Two Interactive Software is expected to unveil its fiscal second-quarter earnings next month, and analysts project a ...
Diwali's festive glow masks a growing concern: colorectal cancer is increasingly striking young adults, a trend alarming ...
Whether it’s safe to stop anti-TNF treatment in patients with inflammatory bowel disease (IBD) in remission remains unclear. In the Spanish EXIT study, anti-TNF withdrawal in selected patients with ...
Good evening, and welcome to Raymond James Financial's Fiscal Fourth Quarter and Fiscal 2025 Earnings Call. This call is being recorded and will be available for replay on the company's Investor ...
What if your gut could hold the key to curing chronic disease? India’s premier science body, the Council of Scientific and ...
Check out the Nebraska high school cross country district results for Classes A and C. [email protected], ...